
|Videos|October 7, 2022
Urology Times 50 Innovations Series: Intracavernosal injections for erectile dysfunction
Author(s)Urology Times staff
Advertisement
Urology Times® is celebrating its 50th anniversary in 2022. To mark the occasion, we are highlighting 50 of the top innovations and developments that have transformed the field of urology over the past 50 years. In this installment, Joshua A. Broghammer, MD, discusses intracavernosal injections for the treatment of patients with erectile dysfunction. Broghammer is an associate professor of Urology at the University of Kansas Medical Center.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
The UroOnc Minute: AUA 2026 Update on Prostate Cancer Early Detection, With Badrinath R. Konety, MBBS
2
FDA approves enfortumab vedotin plus pembrolizumab for MIBC
3
Amy E. Krambeck, MD, on choosing between CVAC and FANS for suction-based ureteroscopy
4
Study suggests tamsulosin deprescribing may be appropriate for select men with BPH
5



















































